Arcturus Therapeutics Holdings (ARCT) Equity Ratio (2018 - 2025)
Arcturus Therapeutics Holdings' Equity Ratio history spans 8 years, with the latest figure at 0.79 for Q4 2025.
- For Q4 2025, Equity Ratio rose 12.68% year-over-year to 0.79; the TTM value through Dec 2025 reached 0.79, up 12.68%, while the annual FY2025 figure was 0.79, 12.68% up from the prior year.
- Equity Ratio reached 0.79 in Q4 2025 per ARCT's latest filing, down from 0.8 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.8 in Q3 2025 to a low of 0.5 in Q3 2022.
- Average Equity Ratio over 5 years is 0.65, with a median of 0.66 recorded in 2024.
- The largest YoY upside for Equity Ratio was 210.95% in 2021 against a maximum downside of 30.2% in 2021.
- A 5-year view of Equity Ratio shows it stood at 0.58 in 2021, then rose by 3.31% to 0.6 in 2022, then increased by 8.07% to 0.65 in 2023, then increased by 7.98% to 0.7 in 2024, then increased by 12.68% to 0.79 in 2025.
- Per Business Quant, the three most recent readings for ARCT's Equity Ratio are 0.79 (Q4 2025), 0.8 (Q3 2025), and 0.75 (Q2 2025).